Literature DB >> 8389910

The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter.

M Carvalho1, D Derse.   

Abstract

The enhancer unit present in the retrovirus equine infectious anemia virus (EIAV) was previously shown to contain binding sites for proteins belonging to MDBP, PEA2, AP-1, and ets families. The EIAV ets motif matches the consensus sequence for both PEA3- and PU.1-binding sites. Here, we show by gel shift analysis that PU.1, present in nuclear extracts from monocyte and B-lymphocyte cell lines, binds to oligonucleotides containing the EIAV ets element. HeLa cells transiently transfected with a PU.1 expression plasmid expressed nuclear factors that formed complexes indistinguishable from those seen with monocyte extracts. Antibodies to PU.1 protein either supershifted or abolished formation of these complexes, depending on the PU.1 epitopes recognized. The binding of PU.1 to the EIAV ets motif in vitro correlated with transcriptional activity of the EIAV promoter in transfected monocyte cell lines. In HeLa cells, the product of PU.1 cDNA bound to the EIAV ets motif and activated transcription from the EIAV promoter. The PU.1-binding site was the primary determinant of EIAV promoter activity in cell lines that express PU.1. Nucleotide determinants of PU.1 binding and a consensus PU.1 binding sequence were defined in gel shift assays using a panel of mutated oligonucleotides. To our knowledge, this is the first report of a retroviral promoter controlled by PU.1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389910      PMCID: PMC237754     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.

Authors:  F Moreau-Gachelin; A Tavitian; P Tambourin
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

Review 2.  The ets gene family.

Authors:  A Seth; R Ascione; R J Fisher; G J Mavrothalassitis; N K Bhat; T S Papas
Journal:  Cell Growth Differ       Date:  1992-05

3.  The ets sequence is required for induction of erythroblastosis in chickens by avian retrovirus E26.

Authors:  M F Nunn; T Hunter
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  cis- and trans-acting regulation of gene expression of equine infectious anemia virus.

Authors:  P L Dorn; D Derse
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

5.  Interaction of a nuclear factor with the polyomavirus enhancer region.

Authors:  P Ostapchuk; J F Diffley; J T Bruder; B Stillman; A J Levine; P Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 6.  Equine infectious anemia virus: immunopathogenesis and persistence.

Authors:  W P Cheevers; T C McGuire
Journal:  Rev Infect Dis       Date:  1985 Jan-Feb

7.  Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.

Authors:  S Schuetze; R Paul; B C Gliniak; D Kabat
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  14 in total

1.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

2.  PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.

Authors:  Robert Hines; Brenda R Sorensen; Madeline A Shea; Wendy Maury
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

4.  Activation of transcription by PU.1 requires both acidic and glutamine domains.

Authors:  M J Klemsz; R A Maki
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

Review 5.  Molecular biology and pathogenesis of animal lentivirus infections.

Authors:  J E Clements; M C Zink
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

6.  Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.

Authors:  D L Lichtenstein; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Monocyte maturation controls expression of equine infectious anemia virus.

Authors:  W Maury
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells.

Authors:  M Huang; M Takac; C A Kozak; P Jolicoeur
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity.

Authors:  M Carvalho; M Kirkland; D Derse
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1.

Authors:  C Van Lint; J Ghysdael; P Paras; A Burny; E Verdin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.